Revenue Dynamics YoY (Last Twelve Months): Viracta Therapeutics (VIRX)

Public company logo of viracta.com (VIRX)

Premium pricing risks in the orphan disease niche are mitigated as the rolling 12-month revenue growth trend filters out market noise, while 0.00 records a new level. Stability is ensured by patents for the Kick & Kill technology, which create a monopoly barrier, and modernized sterile complexes operating on a strict schedule for Viracta Therapeutics (VIRX).

VIRX Viracta Therapeutics: Sales Growth YoY (TTM) in the range 02/11/2024 - 02/20/2024

Viracta Therapeutics Inc. (VIRX) - metric breakdowns and financial figures

- stock value and consensus price forecast:
- company stock exchange capitalization indicators:
Fundamental company valuation:Viracta Therapeutics Inc.
Product sample of Viracta Therapeutics, Inc.

This indicator minimizes fundamental valuation risks, allowing for the tracking of revenue dynamics in real time without waiting for quarterly reports. For Viracta Therapeutics (VIRX), which is scaling its oncology portfolio, such granularity is critical when analyzing the commercialization of lymphoma therapies. The 12-month annual revenue trajectory measures the daily TTM sales growth rate, helping investors promptly assess the sustainability of the business capitalization.

Competitor analysis for Viracta Therapeutics

Annual Revenue Growth (Last Twelve Months) BeiGene Corp (ONC)|HALO - Sales Growth YoY (Last Twelve Months)|RVMD: Sales Growth YoY (Last Twelve Months)|AAPG: Sales Growth YoY (TTM)|Trailing Twelve Months Revenue Growth CG Oncology Inc (CGON)|URGN (urogen.com) - Sales Growth YoY (TTM)|BCAX: Revenue Dynamics YoY (Last Twelve Months)|Sales Growth YoY (Last Twelve Months) Personalis (PSNL)|Sales Growth YoY (TTM) Erasca (ERAS)|Sales Growth YoY (TTM) DCTH (Delcath Systems)|Revenue Dynamics YoY (Last Twelve Months) YMAB|AURA - Sales Growth YoY (Last Twelve Months)|candeltx.com - Revenue Change YoY (Last 12 Months)|ARAY: Sales Growth YoY (TTM)|Trailing Twelve Months Sales Growth SLS (SELLAS Life Sciences Group, Inc.)|ACTU (Actuate Therapeutics) - Sales Growth YoY (TTM)|Revenue Growth YoY (Last 12 Months) Citius Oncology Inc. (CTOR)|Sales Growth YoY (Last Twelve Months) TuHURA (HURA)|TARA - Trailing Twelve Months Revenue Growth|Sales Growth YoY (TTM) FATE (Fate Therapeutics Inc)|Aadi Bioscience Inc (WHWK) - Trailing Twelve Months Revenue Growth|TScan - Sales Growth YoY (TTM)|Champions Oncology, Inc. (CSBR) - Revenue Growth YoY (Last 12 Months)|XBIT (XBiotech Inc.) - Revenue Growth YoY (Last 12 Months)|CEL-SCI Corporation (CVM) - Sales Growth YoY (TTM)|Sales Growth YoY (Last Twelve Months) OS Therapies|RADX: Revenue Dynamics YoY (Last Twelve Months)|Sales Growth YoY (Last Twelve Months) artivabio.com (ARTV)|Annual Revenue Growth (Last Twelve Months) Adlai Nortye|Sales Growth YoY (TTM) VERU (Veru Corporation)|Revenue Change YoY (Last 12 Months) TPST (Tempest Tx)|XLO: Revenue Growth YoY (Last 12 Months)|renovarobio.com (RENB) - Revenue Growth YoY (Last 12 Months)|Mural Bio (MURA) - Sales Growth YoY (Last Twelve Months)|Kairos Pharma Inc (KAPA) - Sales Growth YoY (TTM)|Revenue Growth YoY (Last 12 Months) OKUR|CytoMed Therapeutics (GDTC) - Annual Revenue Growth (Last Twelve Months)|Revenue Growth YoY (Last 12 Months) CRIS (Curis Inc.)|Sales Growth YoY (TTM) Apollomics Inc. (APLM)|Sales Growth YoY (Last Twelve Months) Tharimmune Corp THAR|Advanced Biomed Corp - Sales Growth YoY (Last Twelve Months)|GNPX: Revenue Growth YoY (Last 12 Months)|Calidi Biotherapeutics, Inc. (CLDI) - Revenue Growth YoY (Last 12 Months)|SBFM: Sales Growth YoY (TTM)|Revenue Growth YoY (Last 12 Months) Xenetic Biosciences Inc.|Sales Growth YoY (Last Twelve Months) Salarius Pharmaceuticals Inc|PPBT: Revenue Dynamics YoY (Last Twelve Months)|Sales Growth YoY (TTM) AONC|BGNE (BeOne Medicines) - Revenue Dynamics YoY (Last Twelve Months)|Checkpoint Therapeutics, Inc - Revenue Growth YoY (Last 12 Months)|elevationoncology.com (ELEV) - Trailing Twelve Months Revenue Growth|iCAD Inc. - Sales Growth YoY (TTM)|Trailing Twelve Months Revenue Growth Ikena Oncology|NTBL: Sales Growth YoY (TTM)|Trailing Twelve Months Sales Growth MOR (MorphoSys Corp)|Sales Growth YoY (Last Twelve Months) NAYA Biosciences|Sales Growth YoY (TTM) ascentage.com